Clinical trial
Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated…
NCT00120757 · French National Agency for Research on AIDS and Viral Hepatitis, Other · Completed
Key facts
| NCT number | NCT00120757 |
|---|---|
| Title | Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120) |
| Official title | Efficacy of Alendronate Versus Placebo in the Treatment of HIV-1 Associated Osteoporosis, a Multicenter, Randomized, Controlled Trial. ANRS 120 Fosivir |
| Lead sponsor | French National Agency for Research on AIDS and Viral Hepatitis, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis, HIV Infections |
| Intervention type | Drug |
| Interventions | Alendronate |
| Enrollment | 140 |
| Start date | Oct 1, 2004 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Jul 19, 2005 |
| Last update posted | Dec 22, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: